Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.
Hernandez-Boussard TM, Hainaut P. Hernandez-Boussard TM, et al. Environ Health Perspect. 1998 Jul;106(7):385-91. doi: 10.1289/ehp.98106385. Environ Health Perspect. 1998. PMID: 9637795 Free PMC article.
IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.
Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P. Hernandez-Boussard T, et al. Hum Mutat. 1999;14(1):1-8. doi: 10.1002/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H. Hum Mutat. 1999. PMID: 10447253 Review.
Sources of bias in the detection and reporting of p53 mutations in human cancer: analysis of the IARC p53 mutation database.
Hernandez-Boussard T, Montesano R, Hainaut P. Hernandez-Boussard T, et al. Genet Anal. 1999 Feb;14(5-6):229-33. doi: 10.1016/s1050-3862(98)00030-8. Genet Anal. 1999. PMID: 10084119
Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
Martin AC, Facchiano AM, Cuff AL, Hernandez-Boussard T, Olivier M, Hainaut P, Thornton JM. Martin AC, et al. Hum Mutat. 2002 Feb;19(2):149-64. doi: 10.1002/humu.10032. Hum Mutat. 2002. PMID: 11793474
Analysis of somatic mutations of the p53 gene in human cancers: a tool to generate hypotheses about the natural history of cancer.
Hernandez-Boussard T, Montesano R, Hainaut P. Hernandez-Boussard T, et al. IARC Sci Publ. 1999;(146):43-53. IARC Sci Publ. 1999. PMID: 10353383 Review. No abstract available.
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM. Nielsen TO, et al. Clin Cancer Res. 2004 Aug 15;10(16):5367-74. doi: 10.1158/1078-0432.CCR-04-0220. Clin Cancer Res. 2004. PMID: 15328174
Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Cloyd JM, Yang RL, Allison KH, Norton JA, Hernandez-Boussard T, Wapnir IL. Cloyd JM, et al. Breast Cancer Res Treat. 2014 Dec;148(3):637-44. doi: 10.1007/s10549-014-3207-0. Epub 2014 Nov 16. Breast Cancer Res Treat. 2014. PMID: 25399232
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
Tsai J, Bertoni D, Hernandez-Boussard T, Telli ML, Wapnir IL. Tsai J, et al. Ann Surg Oncol. 2016 Oct;23(10):3310-6. doi: 10.1245/s10434-016-5319-8. Epub 2016 Jul 11. Ann Surg Oncol. 2016. PMID: 27401442
Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983-2009.
Cloyd JM, Hernandez-Boussard T, Wapnir IL. Cloyd JM, et al. Ann Surg Oncol. 2013 May;20(5):1545-50. doi: 10.1245/s10434-013-2918-5. Epub 2013 Mar 5. Ann Surg Oncol. 2013. PMID: 23460016
Long-term results after accessory renal artery coverage during endovascular aortic aneurysm repair.
Greenberg JI, Dorsey C, Dalman RL, Lee JT, Harris EJ, Hernandez-Boussard T, Mell MW. Greenberg JI, et al. J Vasc Surg. 2012 Aug;56(2):291-6; discussion 296-7. doi: 10.1016/j.jvs.2012.01.049. Epub 2012 Apr 4. J Vasc Surg. 2012. PMID: 22480767
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page